Log In
Print
BCIQ
Print
Print this Print this
 

Risperdal, risperidone

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionLong-acting formulation of risperidone
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT) receptor
Mechanism of ActionMonoaminergic receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today